Implantica AG reported earnings results for the first quarter ended March 31, 2021. For the period, the company reported net sales amounted to EUR 82,000 against EUR 23,000 a year ago. Operating loss (EBIT) increased to EUR 2,279,000 against EUR 1,397,000 a year ago. Loss after tax amounted to EUR 1,966,000 against EUR 1,252,000 a year ago. Basic and diluted loss per Class A share amounted to EUR 0.03 against EUR 0.03 a year ago.